ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "X-ray"

  • Abstract Number: 1330 • ACR Convergence 2021

    Effect of Guselkumab (TREMFYA®), a Selective IL-23p19 Inhibitor, on Axial-Related Endpoints in Patients with Active PsA: Results from a Phase 3, Randomized, Double-blind, Placebo-controlled Study Through 2 Years

    Philip Mease1, Philip S Helliwell2, Dafna Gladman3, Denis Poddubnyy4, Xenofon Baraliakos5, Soumya Chakravarty6, Alexa Kollmeier7, Xie Xu8, Shihong Sheng8, Stephen Xu8, May Shawi9, Désirée van der Heijde10 and Atul Deodhar11, 1Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 3Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 4Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany, 5Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 6Janssen Scientific Affairs, LLC and Drexel University College of Medicine, Horsham, PA, 7Janssen Research & Development, LLC, La Jolla, CA, 8Janssen Research & Development, LLC, Spring House, PA, 9Janssen Immunology Global Commercial Strategy Organization, Toronto, ON, Canada, 10Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, 11Oregon Health & Science University, Portland, OR

    Background/Purpose: Guselkumab (GUS), a selective IL-23p19 inhibitor, resulted in greater mean improvements in BASDAI scores vs placebo (PBO) at W24 among patients (pts) with active…
  • Abstract Number: 1582 • ACR Convergence 2021

    Diagnostic Accuracy and Reliability of Conventional Radiography of the Knee in Calcium Pyrophosphate Deposition Disease by Using New Definitions: An Ancillary Study of the OMERACT Ultrasound – CPPD Group

    Silvia Sirotti1, Fabio Becce2, Luca Maria Sconfienza3, Carlos Pineda4, Marwin Gutierrez5, Teodora Serban6, Daryl MacCarter7, Antonella Adinolfi8, Anna Scanu9, Carlo Alberto Scire10, Ingrid Moller11, Esperanza Naredo12, Piercarlo Sarzi-Puttini13, Abhishek Abhishek14, Hyon K. Choi15, Nicola Dalbeth16, Sara Tedeschi17, Maria-Antonietta D'Agostino18, Nemanja Damjanov19, Helen Keen20, Lene Terslev21, Annamaria Iagnocco22 and Georgios Filippou23, 1Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy, 2Lausanne University Hospital, Lausanne, Switzerland, 3Department of Biomedical Sciences for Health, Università Degli Studi di Milano, Milan, Italy, 4Instituto Nacional de Rehabilitacion, Mexico City, Federal District, Mexico, 5Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitacion, Mexico City, Mexico, 6Ospedale La Colletta, ASL3 Genovese, Genoa, Italy, 7Rheumatology Department, North Valley Hospital, Whitefish, MT, 8Rheumatology Unit, Grande Ospedale Metropolitano Niguarda, Milan, Italy, 9Department of Medicine-DIMED, Rheumatology Unit, University of Padova, Padoa, Italy, 10SIR Epidemiology, Research Unit, Pavia, Italy, 11University of Barcelona, Barcelona, Spain, 12Department of Rheumatology and Joint and Bone Research Unit, Hospital Fundación Jiménez Díaz and Autónoma University, Madrid, Spain, 13Rheumatology Department, Luigi Sacco University Hospital, Milano, Italy, 14University of Nottingham, Nottingham, United Kingdom, 15Massachusetts General Hospital, Lexington, MA, 16University of Auckland, Auckland, New Zealand, 17Brigham and Women's Hospital, Boston, MA, 18Rheumatology Department, Università Cattolica del Sacro Cuore, Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy, 19University of Belgrade School of Medicine, Institute of Rheumatology, Belgrade, Serbia, 20University of Western Australia, Daglish, Australia, 21Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University, Glostrup, Denmark, 22University of Turin, Roma, Italy, 23Rheumatology Department, Luigi Sacco University Hospital, Siena, Italy

    Background/Purpose: Conventional Radiography (CR) has been widely used in Calcium Pyrophosphate Deposition Disease (CPPD) and is considered an important tool for the diagnosis. However, there…
  • Abstract Number: 1805 • ACR Convergence 2021

    Low Rates of Radiographic Progression with 2 Years of Guselkumab (TREMFYA®), a Selective Inhibitor of the Interleukin-23p19 Subunit: Results from a Phase 3, Randomized, Double-blind, Placebo-controlled Study of Biologic-naïve Patients with Active Psoriatic Arthritis

    Philip Mease1, Alice Gottlieb2, Iain McInnes3, Proton Rahman4, Alexa Kollmeier5, Xie Xu6, Yusang Jiang6, Shihong Sheng6, May Shawi7, Soumya Chakravarty8, Frederic Lavie9 and Désirée van der Heijde10, 1Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, 2Icahn School of Medicine at Mount Sinai, New York, NY, 3University of Glasgow, School of Medicine, Glasgow, Scotland, United Kingdom, 4Department of Medicine, Eastern Health and Memorial University of Newfoundland, St John's, NL, Canada, 5Janssen Research & Development, LLC, La Jolla, CA, 6Janssen Research & Development, LLC, Spring House, PA, 7Janssen Immunology Global Commercial Strategy Organization, Toronto, ON, Canada, 8Janssen Scientific Affairs, LLC and Drexel University College of Medicine, Horsham, PA, 9Janssen Global Services, LLC, Horsham, PA, 10Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands

    Background/Purpose: Guselkumab (GUS), an IL-23p19-subunit inhibitor, is efficacious in treating patients (pts) with psoriasis and psoriatic arthritis (PsA). In the Phase 3, double-blind, placebo (PBO)-controlled…
  • Abstract Number: 0177 • ACR Convergence 2021

    Dual-Energy Computed Tomography Three Material Decomposition Improves the Sensitivity of Gout Detection

    Justin Tse1, Douglas Kondro2, Yves Pauchard3, Andrea Veljkovic4, Viviane Frasson5, David Holdsworth6, Sarah Manske7, Paul MacMullan8 and Peter Salat7, 1UNIVERSITY OF CALGARY, Calgary, AB, Canada, 2STEMCELL Technologies, Cambridge, United Kingdom, 3Department of Electrical and Software Engineering, Schulich School of Engineering, Calgary, AB, Canada, 4University of British Columbia, Department of Orthopaedics, Vancouver, BC, Canada, 5University of Calgary, Human Performance Lab, Calgary, AB, Canada, 6University of Western Ontario, Department of Surgery, London, ON, Canada, 7University of Calgary, Department of Radiology, Calgary, AB, Canada, 8University of Calgary, Department of Rheumatology, Calgary, AB, Canada

    Background/Purpose: Gout, a curable musculoskeletal disease, is characterized by the deposition and accumulation of monosodium urate (MSU) crystals within affected joints. Dual-energy computed tomography (DECT),…
  • Abstract Number: 0825 • ACR Convergence 2021

    An Investigator-initiated Multicenter Randomized Study in Early Rheumatoid Arthritis of Active Conventional Therapy versus Three Biological Treatments: 48 Week Clinical and Radiographic Results of the NORD-STAR Trial

    Mikkel Ostergaard1, Ronald van Vollenhoven2, Anna Rudin3, Merete Hetland4, Marte S Heiberg5, Dan Nordström6, Michael Nurmohamed7, Bjorn Gudbjornsson8, Lykke Ørnbjerg9, Pernille Bøyesen10, Inge Olsen11, Kristina Lend12, Kim Hørslev-Petersen13, Till Uhlig14, Tuulikki Sokka-Isler15, Gerdur Grondal8, Simon Krabbe16, Joakim Lindqvist17, Inger Gjertsson18, Daniel Glinatsi9, Meliha Kapetanovic19, Anna-Birgitte Aga10, Francesca Faustini20, Pinja Parmanne21, Tove Lorenzen22, Cagnotto Giovanni23, Johan Back24, Oliver Hendricks25, Daisy Vedder26, Tuomas Rannio27, Emma Grenholm28, Maud Kristine Ljoså29, Eli Brodin30, Hanne Merete Lindegaard31, Annika Söderbergh32, Milad Rizk33, Elsa Hermansson34, Per Larsson35, Line Uhrenholt36, Søren Andreas Just37, David John Stevens38, Trine Bay Laurberg39, Gunnstein Bakland40, Espen Haavardsholm41 and Jon Lampa17, 1Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, and Department of Clinical Medicine, University of Copenhagen, Glostrup, Denmark, 2Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 3Rheumatology Clinic, Sahlgrenska University Hospital, Sahlgrenska Academy of University of Gothenburg, Gothenburg, Sweden, 4DANBIO and COPECARE, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Denmark, 5Diakonhjemmet Hospital, Oslo, Norway, 6Division of Internal Medicine and Rheumatology, Helsinki University Hospital, Helsinki, Finland, 7Reade and Amsterdam University Medical Center, location VUmc, Amsterdam, Netherlands, 8Landspitali University Hospital, University of Iceland, Reykjavik, Iceland, 9Copenhagen Center for Arthritis Research, COPECARE, Glostrup, Denmark, 10Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 11Oslo University Hospital, Oslo, Norway, 12Department of Medicine, Rheumatology Unit, The Karolinska Institute, Stockholm, Sweden, 13King Christian X's Hospital for Rheumatic Diseases, Gråsten, Denmark, 14Diakonhjemmet Hospital, University of Oslo, Oslo, Norway, 15University of Eastern Finland, Jyväskylä Central Hospital, Jyväskylä, Finland, 16Radiologisk Afdeling, Herlev Universitetshospital, Herlev, Denmark, 17Karolinska University Hospital, Stockholm, Sweden, 18Dept. of Rheumatology, Sahlgrenska University Hospital, Gothenborg, Sweden, 19Dept. of Clinical Sciences, Skåne University Hospital, Lund, Sweden, 20Dept. of Medicine, Rheumatology, Karolinska University Hospital, Stockholm, Sweden, 21Division of Rheumatology, Helsinki University Hospital, Helsinki, Finland, 22Dept. of Rheumatology, Silkeborg University Hospital, Silkeborg, Denmark, 23Dept. of Clinical Sciences, Skåne University Hospital, Malmö, Sweden, 24Dept. of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden, 25Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark, 26Dept. of Rheumatology, Reade, Amsterdam, Netherlands, 27Finland Central Hospital, Jyväskylä, Finland, 28Dept. of Rheumatology, Falunl, Falun, Sweden, 29Dept. of Rheumatology, Ålesund Hospital, Ålesund, Norway, 30Dept. of Rheumatology, Haukeland University Hospital, Haukeland, Norway, 31Rheumatology Research Unit, Odense University Hospital, Odense, Denmark, 32Dept. of Rheumatology, Örebro University Hospital, Örebro, Sweden, 33Rheumatology Clinic, Västmanlands Hospital Västerås, Västerås, Sweden, 34Dept. of Rheumatology, Linköping University Hospital, Linköping, Sweden, 35Academic Specialist Center, Stockholm, Sweden, 36Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark, 37Section of Rheumatology, Dept. of Medicine, Svendborg Hospital, Svendborg, Denmark, 38Dept. of Rheumatology, University Hospital of Trondheim, Trondheim, Norway, 39Dept. of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 40Dept. of Rheumatology, University Hospital of North Norway, Tromsø, Norway, 41[email protected], Oslo, Norway

    Background/Purpose: The optimal first-line treatment of patients (pts) with early rheumatoid arthritis (eRA) is yet to be established. The main objectives were to assess and…
  • Abstract Number: 0907 • ACR Convergence 2021

    Radiographic Sacroiliitis Progression up to Six Years of Follow-Up in Patients with Non-Radiographic Axial Apondyloarthritis

    Stan Kieskamp1, Rick Wilbrink2, Freke Wink3, Reinhard Bos4, Hendrika Bootsma1, Suzanne Arends1 and Anneke Spoorenberg1, 1University Medical Center Groningen, Groningen, Netherlands, 2University of Groningen, Leeuwarden, Netherlands, 3Medical Center Leeuwarden, Leeuwarden, Netherlands, 4Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, Netherlands

    Background/Purpose: In two years, approximately 10% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) progresses to ankylosing spondylitis (AS). There are no data available of more…
  • Abstract Number: 0921 • ACR Convergence 2021

    Effect of Secukinumab on Radiographic Progression and Inflammation in Sacroiliac Joints and Spine in Patients with Non-radiographic Axial Spondyloarthritis: 2-year Imaging Outcomes from a Phase III Randomized Trial

    Juergen Braun1, Ricardo Blanco2, Helena Marzo-Ortega3, Lianne Gensler4, Filip Van den Bosch5, Stephen Hall6, Hideto Kameda7, Denis Poddubnyy8, Marleen van de Sande9, Désirée van der Heijde10, Tingting Zhuang11, Anna Stefanska12, Aimee Readie11, Hanno Richards13 and Atul Deodhar14, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2Hospital University Marqués de Valdecilla, IDIVAL, Division of Rheumatology, Santander, Spain, 3NIHR Leeds Biomedical Research Centre and University of Leeds, Leeds, United Kingdom, 4Department of Rheumatology, University of California San Francisco, San Francisco, CA, 5Dept. of Rheumatology - Ghent University Hospital, Ghent, Belgium, Ghent, Belgium, 6Emeritus Research and Monash University, Melbourne, Australia, Melbourne, Australia, 7Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, Tokyo, Japan, 8Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany, 9Amsterdam UMC, University of Amsterdam, Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands, 10Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, 11Novartis Pharmaceuticals Corporation, East Hanover, NJ, 12Novartis Ireland Limited, Dublin, Ireland, Dublin, Ireland, 13Novartis Pharma AG, Basel, Switzerland, 14Oregon Health & Science University, Portland, OR

    Background/Purpose: Axial spondyloarthritis (axSpA) is characterized by inflammation of the sacroiliac joints (SIJ) and the spine. Secukinumab (SEC) treatment was clinically efficacious and reduced SIJ…
  • Abstract Number: 1211 • ACR Convergence 2021

    Evaluation of the Cervical Involvement Frequency and Associated Risk Factors in Patients with Rheumatoid Arthritis

    Gulay Alp1, Haluk Cinaklı1, Dilek Solmaz2, Eda OTMAN1, Elif Ediboglu1, Esra Erpek1 and Servet Akar2, 1Izmir Katip Celebi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İzmir, Turkey, 2Izmir Katip Celebi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey

    Background/Purpose: Spinal involvement in Rheumatoid arthritis (RA) is limited to the upper region of the cervical spine which leads to cervical spine instability (CSI); anterior…
  • Abstract Number: 0385 • ACR Convergence 2020

    A Pilot Study to Evaluate the Safety and Efficacy of Treprostinil in the Treatment of Calcinosis in Patients with Systemic Sclerosis

    Melody Chung1, Antonia Maria Valenzuela Vergara2, Benjamin Catanese1, Shufeng Li1, Kate Stevens1 and Lorinda Chung3, 1Stanford University, Stanford, CA, 2Pontificia Universidad Catolica de Chile, Santiago de Chile, Chile, 3Stanford University School of Medicine and Palo Alto VA Health Care System, Palo Alto, CA

    Background/Purpose: Calcinosis is characterized by calcium deposition in skin and subcutaneous tissues and progresses over one year in the majority of systemic sclerosis (SSc) patients. Since…
  • Abstract Number: 0687 • ACR Convergence 2020

    Musculoskeletal Manifestations in Patients with CD73 Deficiency

    Cornelia Cudrici1, Kam Newman2, Deepak Lakshmipathy1, Elisa Ferrante1, Rebecca Huffstutler1, Katherine Carney1, Blas Betancourt2, Markku Miettinen3, James Katz4, Leon Nesti5, Han Wen1, Manfred Boehm6 and Alessandra Brofferio1, 1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3National Cancer Institute, National Institutes of Health, Bethesda, MD, 4NIH NIAMS, Bethesda, MD, 5Clinical and Experimental Orthopaedics, Walter Reed National Military Medical Center, Bethesda, MD, 6Center for Molecular Medicine, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

    Background/Purpose: Arterial calcification due to deficiency of CD73 (ACDC) is a hereditary autosomal recessive ectopic mineralization syndrome caused by loss-of-function mutations in the 5'-nucleotidase Ecto…
  • Abstract Number: 0708 • ACR Convergence 2020

    Differences in Treating Knee Osteoarthritis by Clinician Specialty

    Denise Baldock1 and Casey Zhang2, 1Ipsos MORI, London, England, United Kingdom, 2Ipsos Insight, New York, NY

    Background/Purpose: Current treatment of knee osteoarthritis (OA) is focused primarily around pain relief offering sustained mobility and prioritizing symptom relief over disease progression potentially impacts…
  • Abstract Number: 0760 • ACR Convergence 2020

    X-rays Bone Erosions Are Uncommon in Anti-CCP Positive Individuals At-risk of Rheumatoid Arthritis with Musculoskeletal Symptoms Without Clinical Synovitis, and Do Not Predict the Development of Inflammatory Arthritis

    Andrea Di Matteo1, Kulveer Mankia1, Jacqueline L Nam1, Edoardo Cipolletta2, Leticia Garcia-Montoya3, Laurence Duquenne1, Emma Rowbotham4 and Paul Emery5, 1University of Leeds and Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, 2Polytechnic University of Marche, Rheumatology Unit, Department of Clinical and Molecular Sciences, "Carlo Urbani" Hospital, Jesi (AN), Italy, 3The University of Leeds, Leeds Institute for Rheumatic and Musculoskeletal Medicine, NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK, Leeds, United Kingdom, 4Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK, Leeds, United Kingdom

    Background/Purpose: In individuals at-risk of RA, the identification of reliable biomarkers for the future development of clinical arthritis is of critical importance for risk-stratification and…
  • Abstract Number: 1114 • ACR Convergence 2020

    Longitudinally Assessed Structural Abnormalities on MRI and Relative Contributions to Risk of Incident Radiographic Knee Osteoarthritis over 10 Years of Follow-up

    C. Kent Kwoh1, Ali Guermazi2, Erin Ashbeck3, Chengcheng Hu3, Edward Bedrick3, Leena Sharma4, Charles Eaton5, Marc Hochberg6, Rebecca Jackson7, Timothy McAlindon8, Michael Nevitt9, Jane Cauley10 and Frank Roemer11, 1University of Arizona of Arizona Arthritis Center and Division of Rheumatology, College of Medicine, University of Arizona, Tucson, AZ, 2Boston University School of Medicine, Boston, MA, 3University of Arizona, Tucson, AZ, 4Northwestern University Feinberg School of Medicine, Chicago, IL, 5Department of Family Medicine and Epidemiology, Warren Alpert Medical School of Brown University,Department of Epidemiology, School of Public Health of Brown University, Providence, RI, 6University of Maryland School of Medicine, Baltimore, MD, 7Ohio State University, Columbus, OH, 8Tufts Medical Center, Boston, MA, 9University of California, San Francisco, San Francisco, CA, 10University of Pittsburgh, Pittsburgh, PA, 11Boston University School of Medicine, Boston, MA, and Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany, Erlangen, Germany

    Background/Purpose: MRI has identified joint tissues affected during knee OA development, though the relative importance of structures in the pathogenic process is unknown. Our objective…
  • Abstract Number: 1541 • ACR Convergence 2020

    Ultrasound in Knee Osteoarthritis: Reader Performance, Sonographic Features, and Correlation with Radiographic Findings

    Ogonna Nwawka1, Susan Lee1, Bin Lin2, Said Ibrahim3, Collin Brantner4, Peter Sculco5, Michael Parks1, Mark Figgie6, Laura Donlin1, Dana Orange7, Serene Mirza2, Michael Cross1, Jose Rodriguez1, Thomas Sculco1, Miguel Otero2, William Robinson8, Susan Goodman6 and Bella Mehta5, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, 2Hospital for Special Surgery, New York, 3Weill Cornell Medicine, Cleveland, OH, 4Hospital for Special Surgery, New York, NY, 5Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 6Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 7Rockefeller University, New York, 8Stanford University, Palo Alto, CA

    Background/Purpose: Radiography is the most widespread imaging technique used in the evaluation of knee osteoarthritis (KOA), and MRI is known to be specific in characterization…
  • Abstract Number: 1545 • ACR Convergence 2020

    An Artificial Intelligence (AI) Assistant Identifying Spinal Diffuse Idiopathic Skeletal Hyperostosis on Plain X-rays: A Pilot Deep Learning Study

    Sarah Ringsted1, Nishad Sathe1, Atul Deodhar2 and Dongseok Choi2, 1Oregon Health and Science University, Portland, OR, 2Oregon Health & Science University, Portland, OR

    Background/Purpose: Diffuse idiopathic skeletal hyperostosis (DISH) is a non-inflammatory condition most classically seen in the spine, and is characterized by ossification of the spinal ligaments…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies